APPLICATION
ANDA216278
TYPE
ANDA
ORIGINAL APPROVAL
2023-08-15
LATEST ACTION
2025-08-29
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Discontinued
Products
TIOPRONINDiscontinued
TIOPRONIN 100MG · TABLET, DELAYED RELEASE · ORAL
TIOPRONINDiscontinued
TIOPRONIN 300MG · TABLET, DELAYED RELEASE · ORAL
Approval history
2025-08-29Manufacturing (CMC) · Supplement 2 · unknownAP
2023-08-15UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.